EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunoglobulins in recurrent pregnancy loss: Emerging biomarkers and therapeutic targets

Umme Kulsum, K S Praveen Kumar, Pallavi Shekar, C Kamala, Naidu M Swati Krishnaswami, Ananya Hegde, Lakshitha V Jayakrishna, Meghana Hangala Shivakumaraswamy, Akila Prashant

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-12514-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 31.07.2026. Verfasst von Umme Kulsum und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, JSS Medical College and Hospital, JSS Academy of Higher Education & Research, Mysuru, 570015, Karnataka, India. Hauptthemen laut MEDLINE: Abortion, Habitual, Immunoglobulins. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSS Academy of Higher Education and Research, Mysore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrent pregnancy loss (RPL) is a multifactorial reproductive disorder that affects approximately 1–5% of couples of reproductive age and is associated with considerable emotional and clinical burden. Although several genetic, anatomical, endocrine, infectious, and thrombophilic factors have been implicated, the underlying cause remains unexplained in nearly half of all cases, highlighting the importance of immune dysregulation in disease pathogenesis. Among immune factors, immunoglobulins play pivotal roles in maintaining maternal–fetal immune homeostasis by regulating immune tolerance, complement activation, autoantibody production, and inflammatory signalling. However, dysregulated humoral immune responses may disrupt placental development and fetal tolerance, thereby contributing to pregnancy failure. This review summarises current evidence regarding the biological functions of immunoglobulins in normal pregnancy and their involvement in the pathogenesis of RPL. We discuss the clinical significance of immunoglobulin-associated biomarkers, including antiphospholipid, antinuclear, anti-thyroid, and other pregnancy-related autoantibodies, and evaluate their utility in risk stratification and diagnosis. Emerging immunoglobulin-based therapeutic strategies, particularly intravenous immunoglobulin (IVIG), are reviewed in the context of current clinical evidence and guideline recommendations. Finally, we highlight the potential of comprehensive immunoglobulin profiling, integrated with clinical and molecular biomarkers, to support precision medicine approaches for individualised diagnosis, prognosis, and therapeutic decision-making in women with RPL. Continued mechanistic and translational research will be essential to validate these biomarkers and optimise personalised immunomodulatory interventions for improving pregnancy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, HabitualImmunoglobulinsHumansFemalePregnancyBiomarkersAutoantibodiesImmune ToleranceImmunoglobulins, Intravenous

Stichwörter der Autor:innen

AntibodiesAutoantibodiesBiomarkersImmunoglobulinsIntravenous immunoglobulinMaternal–fetal immune tolerancePrecision medicineRecurrent pregnancy loss

Substanzen

BiomarkersImmunoglobulinsAutoantibodiesImmunoglobulins, Intravenous

Autor:innen und Institutionen

  • Department of Medical Genetics, JSS Medical College and Hospital, JSS Academy of Higher Education & Research, Mysuru, 570015, Karnataka, India.
  • Department of Medical Genetics, JSS Medical College and Hospital, JSS Academy of Higher Education & Research, Mysuru, 570015, Karnataka, India. praveenkumarks@jssuni.edu.in.
  • Department of Biochemistry, JSS Medical College and Hospital, JSS Academy of Higher Education & Research, Mysuru, 570015, Karnataka, India.
  • Department of Obstetrics and Gynaecology, JSS Medical College and Hospital, JSS Academy of Higher Education & Research, Mysuru, 570015, Karnataka, India.
  • SIG-TRRG members, JSS Medical College and Hospital, JSS Academy of Higher Education & Research, Mysuru, 570015, Karnataka, India.

Förderung

  • JSS Academy of Higher Education and Research, Mysore

Zitieren

APA

Kulsum, U., Praveen Kumar, K. S., Shekar, P., Kamala, C., Swati Krishnaswami, N. M., Hegde, A., Jayakrishna, L. V., Shivakumaraswamy, M. H., & Prashant, A. (2026). Immunoglobulins in recurrent pregnancy loss: Emerging biomarkers and therapeutic targets. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12514-2

Vancouver

Kulsum U, Praveen Kumar KS, Shekar P, Kamala C, Swati Krishnaswami NM, Hegde A, et al. Immunoglobulins in recurrent pregnancy loss: Emerging biomarkers and therapeutic targets. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12514-2

BibTeX
@article{Kulsum2026,
  author = {Kulsum, Umme and Praveen Kumar, K S and Shekar, Pallavi and Kamala, C and Swati Krishnaswami, Naidu M and Hegde, Ananya and Jayakrishna, Lakshitha V and Shivakumaraswamy, Meghana Hangala and Prashant, Akila},
  title = {Immunoglobulins in recurrent pregnancy loss: Emerging biomarkers and therapeutic targets},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-12514-2}
}
Kostenlos starten →